Tweed, CD; Dawson, R; Burger, DA; Conradie, A; Crook, AM; Mendel, CM; Conradie, F; ... Spigelman, M; + view all Tweed, CD; Dawson, R; Burger, DA; Conradie, A; Crook, AM; Mendel, CM; Conradie, F; Diacon, AH; Ntinginya, NE; Everitt, DE; Haraka, F; Li, M; Van Niekerk, CH; Okwera, A; Rassool, MS; Reither, K; Sebe, MA; Staples, S; Variava, E; Spigelman, M; - view fewer (2019) Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. The Lancet Respiratory Medicine , 7 (12) pp. 1048-1058. 10.1016/S2213-2600(19)30366-2.